Cardiac Biomarkers and Mortality in Critically Ill Patients With SARS-CoV-2 (COVID-19)

Cardiac Biomarkers and Mortality in Critically Ill Patients With SARS-CoV-2 (COVID-19) : COROBIOCHIC

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04641988

Acronym

COROBIOCHIC

Enrollment

111

Registered

2020-11-24

Start date

2020-02-01

Completion date

2020-06-30

Last updated

2020-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Keywords

SARS-CoV-2, Troponin, hs-cTnT, NT-proBNP

Brief summary

Objective: To assess the prognostic value of high-sensitive cardiac troponin T (hs-cTnT) and N-terminal pro brain natriuretic peptide (NT-proBNP) at ICU admission in patients with coronavirus disease 2019 (COVID-19). Design: Multicenter retrospective observational cohort study Setting: Three ICUs at three hospitals in Occitanie, France. Patients: Adults (≥ 18 years old) with laboratory-confirmed COVID-19 and at least one hs-cTnT measurement at ICU admission, from March 9, 2020, to May 9, 2020.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 99 Years

Healthy volunteers

Inclusion criteria

\- Adults (≥ 18 years old) with laboratory-confirmed COVID-19 and at least one hs-cTnT measurement at ICU admission

Exclusion criteria

\- Age \< 18, pregnancy

Design outcomes

Primary

Measure	Time frame	Description
hs-cTnT	at ICU admission	hs-cTnT

Secondary

Measure	Time frame	Description
NT-proBNP	at ICU admission	NT-proBNP

Countries

France

Outcome results